Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced earnings of $239.5M for Q3 2025, representing 29% year-over-year revenue growth for WAKIX®. These results were driven by the highest ...
Intensity-modulated radiation therapy, or IMRT, is a gentler approach to cancer treatment. It aims to destroy cancer while ...
The authors used a Bayesian modeling framework to fit behavior and serotonin neuron activity to reward history across multiple timescales. A key goal was to distinguish value coding from other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback